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Abstract 
We previously have de:monstrated anobligatory requirement for intracellular reactive oxygen species (ROS) generation 
during T lymphocyte activation, and have proposed that ROS may act as signalling agents in the regulation of certain 
cellular processes, for example, during cell cycle entry. In order to test this hypothesis, we have been interested todetermine 
which, if any, cell cycle entry events are affected by oxidative signalling. Given the requirement for both oxidative 
signalling and altered gene expression during the G O to G l phase transition, we have attempted to establish the extent o 
which oxidative signalling; affects global gene expression patterns during cell cycle entry, and to isolate and characterize 
mRNAs whose expression patterns are responsive to oxidative signalling during this process. Using differential display in a 
phenotypic screening approach, we have identified 10 mRNA species whose expression patterns were altered in response to 
inhibition of oxidative signalling during cell cycle entry. The expression patterns of 4 of these 10 mRNAs were unaffected 
during cell cycle arrest caused by a different mechanism, cyclosporin A-induced interference with calcineurin-mediated 
signalling events, implying that the altered expression patterns een were not simply a consequence of cell cycle arrest. This 
suggests that the expression of these 4 mRNAs is regulated by a mechanism both necessary for cell cycle entry and sensitive 
to oxidative signalling. RNAse protection assays confirmed that 2 of these 4 mRNAs were indeed responsive to redox 
regulation. These observations strongly suggest an involvement for oxidative signalling in the regulation of gene expression 
during the G O to G~ phase transition, in peripheral blood mononuclear cells at least. 
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1. Introduction 
T lymphocyte proliferation is an essential compo- 
nent of the immune response. Under physiological 
conditions normal peripheral T lymphocytes remain 
in a quiescent state until exposed to appropriately- 
presented antigen. Recognition of such antigens by 
* Corresponding author. Present address: Cell Division Cycle 
Laboratory, Imperial Cancer Research Fund Clare Hall Laborato- 
ries, South Mimms, Potters Bar, Hertfordshire EN6 3LD, UK. 
Fax: + 44-0171-269 3801; e-mail: goldston @icrf.icnet.uk 
the T cell antigen receptor complex triggers an inte- 
grated set of biochemical events that drives entry into 
the cell cycle, culminating in cell division [1]. T 
lymphocyte activation may also be mimicked in vitro 
by treatment with a variety of defined mitogens, 
including lectins, antibodies against certain subunits 
of the antigen receptor complex, or a combination of 
phorbol myristate acetate and a calcium ionophore, 
and thus T lymphocytes provide a useful experimen- 
tal model for the study of cellular proliferation. 
After mitogenic stimulation, entry into the cell 
cycle is achieved during an initial 'commitment' 
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period of some 2-3 h, after which the cycle proceeds 
in an autonomous manner, without a continuing re- 
quirement for the initiating mitogen [2]. During this 
commitment period, the intracellular signal transduc- 
tion mechanisms are activated and the expression of a 
number of early genes is initiated. These changes in 
gene expression have been shown to be essential for 
subsequent progress through the cell cycle [3]. 
The intracellular redox balance is intimately linked 
to the cellular proliferative capacity [4-7]. We previ- 
ously have demonstrated, by assessing intracellular 
oxidation of dichlorofluorescin to dichlorofluores- 
cein, the occurrence of a burst of oxidative activity 
related to intracellular reactive oxygen species (ROS) 
formation, detectable by 30 minutes after mitogenic 
stimulation of normal peripheral blood T lympho- 
cytes [8,9]. We also have shown that certain antioxi- 
dant compounds uch as radical scavengers, iron 
chelators and aminothiols not only abrogate this ox- 
idative response, but also inhibit T cell proliferation 
and result in a G l phase cell cycle arrest [8-13]. By 
examining the effect of antioxidant addition at in- 
creasing intervals after mitogenic stimulation on both 
intracellular oxidant generation and DNA synthesis in 
T lymphocytes, we have identified the time-frame of 
action of certain compounds, such as the aminothiol 
cysteamine, as being within the commitment period. 
Given the apparent obligatory requirement for ROS 
formation during T cell activation, and that ROS are 
short-lived products whose generation and destruc- 
tion are tightly controlled, we have proposed that 
ROS may act as signalling agents in the regulation of 
certain cellular processes, for example, during cell 
cycle entry [9]. 
Because both intracellular oxidant generation and 
altered gene expression are required uring cell cycle 
entry, we were interested to explore the nature of the 
link between these two processes. In a previous 
study, we have shown that the IL-2 gene, expression 
of which is absolutely required for T lymphocyte 
proliferation, is responsive to oxidative signalling 
during lymphocyte activation. Furthermore, we have 
shown that the transcription factors AP-1 and NF-K B, 
which play a crucial role in the induction of transcrip- 
tion from the IL-2 promoter, are molecular 'targets' 
for oxidative signalling during mitogenic activation 
of human normal peripheral blood mononuclear cells 
[14]. Having shown that the activity of certain tran- 
scription factors is modulated in a redox-sensitive 
manner, we were interested to determine the extent o 
which endogenous oxidative signalling affects gene 
expression during entry into the cell cycle. To ad- 
dress this question, we have used a phenotypic 
screening approach, differential display [15], to exam- 
ine the effect of antioxidant treatment on global early 
gene expression patterns during cell cycle entry in 
normal human peripheral blood mononuclear cells. 
2. Materials and methods 
2.1. Cell culture 
Mononuclear cells were isolated from human pe- 
ripheral blood buffy coat preparations by centrifuga- 
tion over Ficoll-Hypaque lymphocyte separation 
medium, followed by passage over Sephadex G-10 
columns to deplete adherent cells. The resultant cell 
preparations were plated at a density of 5 × 105 
cel ls/cm 2 and cultured in RPMI 1640 medium + 
10% (v/v) foetal calf serum in an atmosphere of 
95% air/5% CO 2 at 37°C for up to 72 h post-isola- 
tion with little loss of viability, as assessed by Trypan 
blue staining. When required, the cells were stimu- 
lated by treatment with a combination of phorbol 
myristate acetate at 20 ng/ml  and ionomycin at 100 
ng/ml. The antioxidant used in this study was the 
aminothiol compound cysteamine, which we previ- 
ously have shown to inhibit lymphocyte proliferation 
with essentially complete inhibition apparent at a 
dose of 400 /zM [13,14]. The structurally-related 
compound ethanolamine, which lacks the thiol moi- 
ety of cysteamine and at an equivalent dose does not 
affect lymphocyte proliferation, was used as a control 
agent. Cyclosporin A was used at a dose of 20 /zM 
where cell cycle arrest via a non-oxidative mecha- 
nism was necessary, and 25 /zM H20 2 as an extra- 
cellular oxidant source. All agents were added to 
cultures at the time of stimulation, immediately prior 
to plating. Lymphocyte proliferation was routinely 
assessed by determining the incorporation of 
[3H]thymidine into DNA 48 h after stimulation [14]. 
2.2. RNA extraction and differential display 
For RNA extraction, 1X 107 cells from each dif- 
ferent reatment group were plated and cultured for 2 
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h. Total RNA was then extracted from each culture 
using the method of Chomzynski and Sacchi [16]. To 
ensure that the RNA samples were free of contami- 
nating genomic DNA, they were treated with 1U 
RNAse-free DNAse per 10 /zg RNA for 30 min at 
room temperature, then phenol-chloroform extracted, 
and precipitated in the presence of 300 mM sodium 
acetate and 2.5 volumes of ethanol, prior to resuspen- 
sion at a final concentrati.on f 500 ng/ml.  To gener- 
ate the mRNA expression profiles, 2.5 /~g total RNA 
from each sample was reverse transcribed using an- 
chored 3' primers (either TllCA or TIIGC) to prime 
cDNA synthesis. Reactions consisted of 2.5 /zg total 
RNA, 5 /zM primer, 50 mM Tris-HC1 (pH 8.3), 40 
mM KC1, 10 mM DT]?, 7 mM MgC12, 20 /xM each 
dNTP and 200 U M-MLV reverse transcriptase in a 
total volume of 20 /~1, .and were incubated at 37°C 
for 90 min. After inactiwltion of the reverse transcrip- 
tase by heating at 95°C for 3 min, the cDNA samples 
were subjected to 40 cycles of amplification using the 
polymerase chain reaction (PCR) with the appropriate 
3' primer and a random 10-mer as a 5' primer, 
according to the method of Liang and Pardee [15]. 
The sequences of the 5' primers used in this study 
were AGACGTCCAC,  CTGCATCGTG,  
GGAAGTCGCC,  GGTCGGAGAA and TG- 
TAGCTGGG. PCR reactions consisted of 1 /zl cDNA 
from the reverse transcription reaction, 10 mM Tris- 
HCI (pH 9.0 at 25°C), 5c) mM KC1, 1.5 mM MgC12, 
0.1% Triton X-100, 5 /xM 3' primer, 0.5 /xM 5' 
primer, 2 /~M each dNTP, 1 /zM [ cr35S]dATP and 
0.1 U Taq polymerase. Following an initial 5 min 
denaturation step, the amplification parameters used 
were denaturation at95°C for 30 s, annealing at 40°C 
for 1 min, and extension at 72°C for 30 s, with a final 
5-min extension after the last amplification round. 
After the PCR step, 3 /zl of each reaction was 
subjected to electrophoresis on a standard sequencing 
gel. Using this protocol, autoradiographic exposure 
times were between 1-4 days. Each individual fin- 
gerprint run was repeated three times, from indepen- 
dent RNA preparations. 
2.3. Reamplification, cloning and DNA sequencing 
Candidate bands were excised from the dried gels, 
and rehydrated by soaking in 200 /zl sterile H20 for 
15 min. DNA was then eluted from the rehydrated 
gel slices by boiling the samples for 15 min, followed 
by a 30-min incubation at room temperature. The 
samples were then centrifuged at 15000 rpm for 5 
min in a microcentrifuge, and the supernatant recov- 
ered. This was either used directly as a target DNA 
source for reamplification, or precipitated in the pres- 
ence of 300 mM sodium acetate, 10 mM MgC12 and 
2 volumes of ethanol, and resuspended in 20/z l  H20 
prior to reamplification. For the reamplification reac- 
tions, a series of aliquots ranging from 1-12.5 /zl of 
the target DNA solution were subjected to PCR in a 
50 /zl reaction volume using essentially the same 
reaction conditions as for the fingerprint generation, 
with the only modifications being the omission of 
[ a-35S]dATP from the reactions and reduction of the 
annealing time to 30 s. Two sequential rounds of 25 
amplification cycles each, with 10% of the first round 
reaction volume serving as target DNA source for the 
second round, were usually sufficient to generate 
enough product o visualise after electrophoresis and 
ethidium bromide staining. 
PCR products were passed over Magic PCR-prep 
purification columns (Promega) to removed excess 
primers, then cloned directly in the pCR-Script vector 
(Stratagene). The ligation reactions consisted of 1-5 
/zl aliquots of the column-purified PCR product, 10 
ng SrfI pre-digested vector, 25 mM Tris-HC1 (pH 
7.5), 10 mM MgC12, 10 mM DTT, 20 /zg/ml BSA, 
0.5 mM rATP, 5 U SrfI and 1 U T4 DNA ligase. 
Following incubation at room temperature for 1 h, the 
reactions were stopped by heating at 65°C for 10 min, 
then transformed into XL-1 Blue MRF'kan r E. coli. 
At least 10 white colonies were picked from each 
plate and plasmid DNA prepared from each colony. 
Those containing insert of the expected size were 
selected for DNA sequence analysis, which was car- 
ried out using a commercial kit (Cyclist Exo- Pfu, 
Stratagene). 
2.4. RNAse protection 
For the RNAse protection assays, 10/zg RNA was 
hybridized with 5 X 10 6 cpm of an antisense RNA 
probe generated by in vitro transcription. The tran- 
scription reactions consisted of 40 mM Tris-HC1 (pH 
7.5), 6 mM MgC12, 10 mM NaC1, 10 mM DTT, 500 
/zM each GTP, ATP and CTP, 12.5 /zM UTP, 500 
ng linearized template DNA, 2 mM spermidine, 20 U 
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rRNAsin ribonuclease inhibitor and 50 /zCi [a- 
32p]UTP, and were initiated by the addition of 20 U 
of the appropriate RNA polymerase (T3 or T7, de- 
pending on the construct used), and incubated for 60 
min at 37°C. The DNA template was then removed 
by digestion with 0.5 U RNAse-free DNAse for 15 
min at room temperature. After phenol-chloroform 
extraction, the probes were ethanol precipitated, re- 
covered by centrifugation and resuspended in water 
as required. 
Hybridizations were carried out overnight at 55°C 
in a buffer consisting of 40 mM Pipes (pH 6.4), 400 
mM NaC1, 1 mM EDTA and 80% formamide in a 
total volume of 20 /xl. Following hybridization, the 
reactions were diluted 20-fold by the addition of 
RNAse digestion buffer, consisting of 10 mM Tris- 
HC1 (pH 7.5), 300 mM NaC1, 5 mM EDTA, and 
excess probe removed by digestion with 10 U 
RNAseONE (Promega) for 60 min at room tempera- 
ture. The reactions were then stopped by the addition 
of 20 ~1 20% SDS, ethanol precipitated, and resus- 
pended in 10/zl gel loading buffer consisting of 80% 
formamide, 1 mM EDTA and 0.1% each bromophe- 
nol blue and xylene cyanol prior to electrophoresis on
a standard sequencing gel. 
3. Results 
Short-term cultures of human normal peripheral 
blood mononuclear cells were used in this study, and 
the antioxidant used as a probe was the aminothiol 
compound cysteamine. This agent can act as a radical 
scavenger, but may also influence the intracellular 
redox state by serving as a precursor for glutathione 
synthesis [17]. We have previously shown that cys- 
teamine inhibits mitogen-induced intracellular oxi- 
dant generation, transcription factor DNA binding 
activity, IL-2 gene expression, and DNA synthesis in 
a dose-dependent manner in T lymphocytes, exerting 
its effect within the first 2-3 h following mitogenic 
stimulation [13,14]. 
The candidate selection strategy used in this study 
involved firstly the comparison of mRNA expression 
profiles generated from unstimulated cells with those 
from stimulated cells 2 h after mitogenic activation, 
in order to identify the set of mRNAs whose expres- 
sion was altered during cell cycle entry. The expres- 
sion patterns of this set of 'proliferation-related' mR- 
NAs was then compared with those generated from 
cells treated with cysteamine at the time of stimula- 
tion, to enable the identification of proliferation-re- 
lated mRNAs whose expression was altered in re- 
sponse to interference with oxidative signalling dur- 
ing cell cycle entry. In order to select mRNAs from 
within this subpopulation whose expression was al- 
tered in response to interference with oxidative sig- 
nalling rather than as a simple consequence of cell 
cycle arrest, the mRNA expression profiles generated 
mRNA Expression Profiles 
Tll CA- OPH03 T11 CA- OPH07 
Fig. 1. mRNA expression profiles generated bydifferential dis- 
play using two separate primer combinations, with T 11CA as the 
3' primer and AGACGTCCAC (OPH03) and CTGCATCGTG 
(OPH07) as the 5' primers. Arrows indicate mRNA species 
identified as candidates after 3 independent experiments u ing 
these primer combinations. 
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Fig. 2. Expression analysis of the mRNAs represented byclones 31 and 76, as determined byRNAse protection assays. The marker used 
was HinfI digested ~X174 DNA end-filled using Klenow polymerase, and thus the estimated size of the protected RNA fragments 
appears approximately 10% greater in each case than the expected 149 and 140 bases, respectively. 
from mitogen-stimulated cells treated with cys- 
teamine were compared with those generated from 
mitogen-stimulated cells treated with cyclosporin A, 
an agent which induces cell cycle arrest by a non- 
oxidative mechanism, interference with calcineurin 
function [18]. As further controls, the mRNA profiles 
from cysteamine-treated cells were also compared 
with profiles generated from cells treated with 
ethanolamine, a structural analogue of cysteamine 
which has no effect on lymphocyte proliferation [14], 
and with profiles from cells treated with hydrogen 
peroxide, an agent which induces exogenous oxida- 
tive stress. 
In a preliminary screen involving 10 different 
primer combinations, covering approximately 1500 
mRNA species, we have identified 51 mRNAs show- 
5' AGACGTCCACI'AAGGAGAATTGAAAAAAACTrGATATGACTC-CAAA 
TGATACTrAAGCAGATLT 1 TAT 1T IT  1NAGATGAATCAGAATGTrCCTC 
CTTCCCCGACTACCTI'CTCTGACTGTC'Iq'CCAGTI'ACTGTGGTGAAAA 
AAAAAA 3' 
Fig. 3. DNA sequence of clone 31. Primer sequence is under- 
lined. 
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5' IT ITF  H T ITICACCAGITI' I  AGCATC,-CAAuITI ATrAACAACATGTA 
AATAAAATCrNAAAAGAATACACATATCAATATNAACK2qCAGAAGTAT 
AGCTTNCTCAGGATGAATAGATTCATrATCAGGTCACGATGCAG 3' 
Fig. 4. DNA sequence of clone 76, with primer sequences 
underlined. 
ing induced expression during cell cycle entry. Of 
these, the expression of 10 was inhibited by cys- 
teamine treatment. From this subset, 4 mRNA species 
were unaffected by cyclosporin A treatment, suggest- 
ing that their expression was directly regulated by 
oxidative signalling during cell cycle entry (Fig. 1). 
We have cloned the cDNAs representing each of 
these candidates, and have further characterized each 
of them by RNAse protection assay and DNA se- 
quencing. Of the 4 candidates which appeared to be 
directly regulated by oxidative signalling, 2 showed 
differential expression in RNAse protection assays, 
and thus are valid candidates (Fig. 2). DNA sequence 
analysis of these two candidates, clones 31 and 76, 
and comparison with the DNA sequence databases 
indicated that they were both novel genes, although 
clone 76 has been previously reported as an ex- 
pressed sequence tag (EST) isolated from a human 
infant brain cDNA library. Both clones are short, 
clone 31 being 149 bp (Fig. 3), and clone 76 140 bp 
in length (Fig. 4), and most likely represent 3' un- 
translated sequences, given the method by which they 
were generated. Investigation of the biochemical 
function of all candidates will require further charac- 
terization of each by isolation of full-length cDNAs, 
DNA sequencing, and more detailed expression anal- 
ysis. 
4. Discussion 
Given the apparent obligatory requirement for 
intracellular oxidant generation during cell cycle en- 
try in peripheral blood mononuclear cells, and the 
well-described role of altered gene expression during 
the G O to G~ phase transition, we have been inter- 
ested to identify the nature of the link, if any, be- 
tween these two phenomena. We previously have 
shown that cysteamine inhibits intracellular oxidant 
generation, AP-1 and NF-KB DNA binding activity, 
IL-2 gene expression and DNA synthesis in a dose- 
dependent manner in normal human peripheral blood 
mononuclear cells, exerting its effect within the first 
2-3 h following mitogenic stimulation [13,14]. Fur- 
thermore, there is now considerable evidence to sug- 
gest a role for redox regulation of transcription factor 
function [22-25], thereby identifying a mechanism 
by which a link between oxidative signalling pro- 
cesses and gene expression may be established. How- 
ever, the wider role of oxidative signalling in the 
regulation of gene expression remains relatively un- 
explored. 
Changes in the expression patterns of a number of 
"early response" genes have been reported to occur 
in mammalian systems in response to oxidative stress. 
These include c-myc, c-fos, c-jun and EGR1, all of 
which encode transcription factors, and thus have the 
potential to further modulate gene expression [ 19-21 ]. 
More recent investigations by a number of groups 
have demonstrated a role for redox regulation of 
transcription factor function. For example, Staal et al. 
[22] have shown that the redox status of the cell plays 
a key role in the regulation of the function of NF-K B, 
in that depletion of intracellular low molecular weight 
thiols, the major determinants of cellular redox bal- 
ance, was found to occur after mitogenic stimulation 
of a human embryonic kidney-derived cell line, and 
to be required for activation of NF-KB function in 
this cell line and also in the human leukaemic T cell 
line Jurkat. Subsequently, Schreck et al. [23] showed 
that oxidative stress, generated by treatment with low 
extracellular concentrations of H202, was capable of 
inducing NF-KB DNA binding activity in Jurkat 
cells. Treatment of a variety of transformed cell lines 
with antioxidant thiol compounds such as N-acetylcy- 
steine and pyrrolidine dithiocarbamate has been 
demonstrated to modulate the DNA binding activity 
and transactivation capacity of both AP-1 and NF-K B 
[24,25]. Taken together, these data suggest a mecha- 
nism by which oxidative signalling may regulate 
gene expression, both in response to oxidative stress 
and also during cell cycle entry. 
Having identified transcription factors AP-1 and 
NF-KB as molecular targets for oxidative signalling 
during mononuclear cell activation, we were inter- 
ested to establish the extent to which oxidative sig- 
nalling affects early changes in global gene expres- 
sion patterns during cell cycle entry, and to isolate 
and characterize mRNAs whose expression patterns 
are responsive to oxidative signalling during the G O 
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to G 1 phase transition period. To address these ques- 
tions, we have used differential display with a nega- 
tive selection strategy as a convenient screening 
method. 
This selection strategy involved the simultaneous 
comparison of mRNA expression profiles generated 
from stimulated and unstimulated cells, with those 
generated from cells treated with either cysteamine, 
cyclosporin A, ethanolamine or hydrogen peroxide. 
Using this strategy, 51 proliferation-related mRNAs 
were identified, of which 10 showed altered expres- 
sion in response to interference with oxidative sig- 
nalling by cysteamine treatment. The expression pat- 
terns of 4 of these 10 mRNA species were not 
correspondingly affected by cyclosporin A treatment, 
suggesting that these 4 mRNAs are directly respon- 
sive to oxidative signalling during cell cycle entry. 
Interestingly, the expression patterns of the 41 prolif- 
eration-related mRNAs apparently unresponsive to 
oxidative signalling were also unaffected by cy- 
closporin A treatment. It should be noted that the 6 
proliferation-related mRNAs whose expression pat- 
terns were similarly altered in response to treatment 
with either cysteamine or cyclosporin A cannot nec- 
essarily be excluded as candidates for genes regulated 
by oxidative signalling, as the distinction between 
causal and consequential changes in expression pat- 
terns cannot be made in this case. 
From this preliminary study, it would appear that 
there is a significant degree of linkage between ox- 
idative signalling and the global changes in gene 
expression profiles that occur during cell cycle entry. 
Within the total RNA pool examined in this study, 
approximately 20% of the set of mRNA species 
showing induced expression 2 h after mitogenic stim- 
ulation would appear to be sensitive to cell cycle 
arrest induced either by interference with oxidative 
signalling events, or with calcineurin-mediated sig- 
nalling. From this set of proliferation-related mRNAs 
approx. 8% are sensitiw~ to interference with oxida- 
tive signalling events alone. Taken in the context of 
the apparent obligatory requirement for intracellular 
reactive oxygen species generation during cell cycle 
entry [8-13], together with the now well-demon- 
strated role for redox regulation of transcription fac- 
tor function [22-25], these observations uggest an 
intimate relationship between oxidative signalling and 
gene expression during the G O to G 1 phase transition, 
in normal human peripheral blood mononuclear cells 
at least. 
Our data indicate that differential display is a 
powerful tool for the study of transcriptional signal- 
and-response r lationships, both in terms of establish- 
ing linkage between the signal and the response, and 
also for the identification of responsive genes. In this 
preliminary study, we have identified 2 novel genes 
that are responsive to oxidative signalling during cell 
cycle entry. Further characterization of these genes, 
and the other candidates identified in this study, will 
be necessary for full investigation of their biological 
function. We are currently continuing our screen for 
genes responsive to oxidative signalling, in order to 
establish more fully the nature of the relationship 
between oxidative signalling and the regulation of 
gene expression during cell cycle entry, and to iden- 
tify genes so regulated. 
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